Prazosin hydrochloride - Generic Drug Details

What are the generic sources for prazosin hydrochloride and what is the scope of freedom to operate?

Prazosin hydrochloride is the generic ingredient in three branded drugs marketed by Pfizer, Alembic, Am Therap, Ani Pharms, Appco, Aurobindo Pharma Ltd, Dava Pharms Inc, Granules, Lannett Co Inc, Mankind Pharma, MSN, Mylan, Novitium Pharma, Purepac Pharm, Teva Pharms, and Watson Labs, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

Thirty-four suppliers are listed for this compound.

Summary for prazosin hydrochloride

US Patents:	0
Tradenames:	3
Applicants:	16
NDAs:	25
Finished Product Suppliers / Packagers:	34
Raw Ingredient (Bulk) Api Vendors:	117
Clinical Trials:	71
Patent Applications:	3,754
What excipients (inactive ingredients) are in prazosin hydrochloride?	prazosin hydrochloride excipients list
DailyMed Link:	prazosin hydrochloride at DailyMed

Recent Clinical Trials for prazosin hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Pfizer	PHASE1
National Institute of Neurological Disorders and Stroke (NINDS)	PHASE2
University of Wisconsin, Madison	PHASE2

See all prazosin hydrochloride clinical trials

Pharmacology for prazosin hydrochloride

Drug Class	alpha-Adrenergic Blocker
Mechanism of Action	Adrenergic alpha-Antagonists

Medical Subject Heading (MeSH) Categories for prazosin hydrochloride

Adrenergic alpha-1 Receptor Antagonists

Antihypertensive Agents

Anatomical Therapeutic Chemical (ATC) Classes for prazosin hydrochloride

C02CA	Alpha-adrenoreceptor antagonists
C02C	ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
C02	ANTIHYPERTENSIVES
C	Cardiovascular system

US Patents and Regulatory Information for prazosin hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072575-001	May 16, 1989	AB	RX	No	No
Ani Pharms	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072577-002	May 16, 1989		DISCN	No	No
Msn	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	216727-001	Sep 17, 2024	AB	RX	No	No
Teva Pharms	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	071745-002	Sep 12, 1988	AB	RX	No	No
Msn	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	216727-003	Sep 17, 2024	AB	RX	No	No
Mylan	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072575-003	May 16, 1989	AB	RX	No	No
Am Therap	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072783-001	May 16, 1989		DISCN	No	No

Expired US Patents for prazosin hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	MINIPRESS XL	prazosin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	019775-002	Jan 29, 1992
Pfizer	MINIPRESS XL	prazosin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	019775-001	Jan 29, 1992
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-002	Approved Prior to Jan 1, 1982
Pfizer	MINIPRESS XL	prazosin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	019775-002	Jan 29, 1992
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-003	Approved Prior to Jan 1, 1982
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-001	Approved Prior to Jan 1, 1982
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-003	Approved Prior to Jan 1, 1982